Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

scientific article

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.3350/CMH.2017.0069
P932PMC publication ID5760000
P698PubMed publication ID29198095

P50authorJeong-Hoon LeeQ52646542
P2093author name stringJoon Yeul Nam
P2860cites workViral Quasi-Species Evolution During Hepatitis Be Antigen SeroconversionQ58002623
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Q30391932
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapyQ33417353
AASLD guidelines for treatment of chronic hepatitis B.Q34501660
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for managementQ36863124
Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance.Q37643680
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionQ38692559
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience.Q40058881
No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B.Q42277100
Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analoguesQ43149262
Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.Q45395245
Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.Q45405023
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.Q46981468
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectentecavirQ418586
chronic hepatitis BQ55779876
P304page(s)311-313
P577publication date2017-12-04
P1433published inClinical and molecular hepatologyQ26853927
P1476titleIs it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
P478volume23

Search more.